Table 2.
Risk Factors for Persistent Body Image Disturbance at 9 Months Posttreatment Relative to Baseline (n = 44).
| Characteristic | n | OR (95% CI) |
|---|---|---|
| Age, y | ||
| ≥40 | 41 | Ref |
| <40 | 3 | 2.82 (0.25–63.69) |
| Sex | ||
| Male | 25 | Ref |
| Female | 19 | 1.00 (0.12–1.44) |
| BMI | ||
| Overweight/obese | 29 | Ref |
| Underweight or normal weight | 15 | 1.24 (0.35–4.40) |
| Preoperative mood disorder | ||
| No | 28 | Ref |
| Yes | 16 | 1.04 (0.29–3.60) |
| Preoperative psychiatric medication | ||
| No | 29 | Ref |
| Yes | 15 | 1.24 (0.35–4.40) |
| Preoperative hypothyroidism | ||
| No | 33 | Ref |
| Yes | 11 | 1.13 (0.28–4.51) |
| Shame and Stigma Scale | 42 | 1.01 (0.95–1.06) |
| PROMIS SF 4a | ||
| Anxiety | 43 | 1.04 (0.90–1.20) |
| Depression | 43 | 1.01 (0.87–1.17) |
| Social isolation | 44 | 1.06 (0.88–1.28) |
| AJCC pathologic T classification | ||
| 0-2 | 27 | Ref |
| 3-4b | 17 | 1.91 (0.56–6.73) |
| Reconstruction | ||
| None/dermal substitute | 13 | Ref |
| Regional flap | 3 | 0.58 (0.02–7.68) |
| Microvascular free flap | 28 | 0.88 (0.23–3.36) |
| Osseous flap reconstruction | ||
| No | 38 | Ref |
| Yes | 6 | 3.07 (0.53–24.18) |
| Adjuvant therapy | ||
| None | 19 | Ref |
| Radiation or chemoradiation | 25 | 1.58 (0.47–5.53) |
Abbreviations: AJCC, American Joint Committee on Cancer; BMI, body mass index; OR, odds ratio; PROMIS SF, Patient-Reported Outcomes Measurement Information System Short Form.